Brief: ICAD And Solis Mammography Ink Deal To Collaborate On Use Of Ai To Evaluate Risk Of Cardiovascular Disease
11/10/2022 13:08
Oct 11 (Reuters) - ICAD Inc ICAD.O :
* ICAD AND SOLIS MAMMOGRAPHY INK DEAL TO COLLABORATE ON USE
OF AI
TO EVALUATE RISK OF CARDIOVASCULAR DISEASE
Source text for Eikon: ID:nGNX8NYD4N
Further company coverage: ICAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on icad
See all newsIcad Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: iCAD, Inc. Q1 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Cognex, Equifax, Netflix
RadNet falls after $103 million all-stock acquisition to buy iCAD